Literature DB >> 15579187

Insulin sensitivity and coronary vasoreactivity: insulin sensitivity relates to adenosine-stimulated coronary flow response in human subjects.

N Dagres1, B Saller, M Haude, J Hüsing, C von Birgelen, A Schmermund, S Sack, D Baumgart, K Mann, R Erbel.   

Abstract

OBJECTIVE: Diabetes is associated with coronary microvasculature abnormalities and impaired coronary flow reserve (CFR). CFR is the ratio of coronary flow under maximal vasodilation to basal flow and is a measure for coronary vasoreactivity. Insulin resistance is the central defect in the development of type 2 diabetes, preceding its onset by 10-20 years. Thus, the relationship between insulin sensitivity and CFR in nondiabetic subjects is particularly interesting. The aim of the study was to investigate this relationship.
DESIGN: Cross-sectional study. PATIENTS: The study population consisted of 18 nondiabetic subjects without coronary artery stenosis on coronary angiography. We excluded patients with structural heart disease or with conditions affecting CFR or insulin sensitivity such as low density lipoprotein (LDL)-cholesterol > or = 4.14 mmol/l, smoking, hypertension or obesity with a body mass index (BMI) > 28 kg/m(2). MEASUREMENTS AND
RESULTS: CFR was 3.1 +/- 0.8 (range 1.7-4.8), as assessed by intracoronary Doppler measurements in the left anterior descending coronary arteries after adenosine stimulation. Intravascular ultrasound revealed zero to moderate coronary atherosclerotic changes. Whole-body insulin sensitivity (M-value) was 7.5 +/- 2.9 mg/kg/min (range 2.2-12.6), as assessed by the hyperinsulinaemic-euglycaemic clamp test. Subjects with low CFR (< 3.0) had a significantly lower M-value than subjects with normal CFR (> 3.0) (6.0 +/- 2.5 vs. 9.0 +/- 2.5 mg/kg/min, P = 0.021). Univariate linear regression demonstrated a strong correlation between CFR and M-value (r = 0.76, P < 0.001). In multiple regression analysis, the significant association of CFR with M-value was independent of potential confounders (sex, age, BMI, LDL-cholesterol and plaque burden on intravascular ultrasound). Bootstrap analysis corroborated this finding.
CONCLUSIONS: Whole-body insulin sensitivity relates to coronary vasoreactivity. Across a wide range of both insulin sensitivity and coronary flow reserve from markedly abnormal to normal values, an increase in insulin sensitivity appears to be associated with an increase in coronary flow reserve. Insulin resistance is therefore associated with coronary microvasculature abnormalities in nondiabetics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15579187     DOI: 10.1111/j.1365-2265.2004.02156.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  13 in total

Review 1.  Influence of obesity and metabolic dysfunction on the endothelial control in the coronary circulation.

Authors:  Eric J Belin de Chantemele; David W Stepp
Journal:  J Mol Cell Cardiol       Date:  2011-08-26       Impact factor: 5.000

2.  Aldosterone impairs coronary adenosine-mediated vasodilation via reduced functional expression of Ca2+-activated K+ channels.

Authors:  Maloree Khan; Alex I Meuth; Scott M Brown; Bysani Chandrasekar; Douglas K Bowles; Shawn B Bender
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-14       Impact factor: 4.733

3.  Metabolic syndrome reduces the contribution of K+ channels to ischemic coronary vasodilation.

Authors:  Léna Borbouse; Gregory M Dick; Gregory A Payne; Zachary C Berwick; Zachary P Neeb; Mouhamad Alloosh; Ian N Bratz; Michael Sturek; Johnathan D Tune
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-29       Impact factor: 4.733

Review 4.  Microvascular responsiveness in obesity: implications for therapeutic intervention.

Authors:  Zsolt Bagi; Attila Feher; James Cassuto
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 5.  Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.

Authors:  Nagara Tamaki; Keiichiro Yoshinaga
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

Review 6.  [Endocrine disorders and the heart].

Authors:  Onno E Janssen; K Mann; R Erbel
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

7.  Myocardial Microvascular Physiology in Acute and Chronic Coronary Syndromes, Aortic Stenosis, and Heart Failure.

Authors:  Alf I Larsen; William F Fearon; Todd J Anderson; Nico Pijls
Journal:  J Interv Cardiol       Date:  2022-01-26       Impact factor: 1.776

Review 8.  Coronary microvascular dysfunction: an update.

Authors:  Filippo Crea; Paolo G Camici; Cathleen Noel Bairey Merz
Journal:  Eur Heart J       Date:  2013-12-23       Impact factor: 29.983

9.  Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesia.

Authors:  R Maharaj
Journal:  J Saudi Heart Assoc       Date:  2012-02-01

Review 10.  Noninvasive assessment of preclinical atherosclerosis.

Authors:  Helen A Lane; Jamie C Smith; J Stephen Davies
Journal:  Vasc Health Risk Manag       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.